M2 Presswire - Allergan Court Victory and Generic Neurontin Launched.
M2 PRESSWIRE-11 October 2004-Financial Relations Inc: Allergan Court Victory and Generic Neurontin Launched(C)1994-2004 M2 COMMUNICATIONS LTD RDATE:10112004 City of Industry, CA - Allergan, Inc. (NYSE:AGN) announced today that the jury in the Irena Medavoy vs. Arnold Klein, M.D., and Allergan, Inc.
Related Results
Warner-Lambert earnings up 36.8%
Other treatment options for menopausal symptoms
Pfizer Japan Obtains Manufacturing Approval of Gabapentin for
Recent approvals spur CNS category. (central nervous system)
Serono link with Pfizer gives Rebif a U.S. marketing push
lawsuit found that Allergan’s product BOTOX (botulinum toxin type A) was not responsible for the conditions Irena Medavoy alleged she suffered following her treatment with BOTOX for migraine. Alpharma Inc. (NYSE:ALO) on Friday began selling a cheaper generic version of Pfizer Inc.’s …
Read the rest of this article with a Free Trial at HighBeam Research.